Ranbaxy woes don't seem to end - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Ranbaxy woes don't seem to end

Sep 25, 2013

Here is today's recommended reading list from Equitymaster...

Ranbaxy woes don't seem to end
Since the first legal case slammed in 2007 by a former employee for forging drug clinical trial studies, the ghost of inadequate practices keep haunting Ranbaxy. Recently, United States Food & Drug Administration imposed a ban on the firm's new plant at Mohali in Punjab, making it the third ban on a Ranbaxy plant in five years. In its rush to capitalize on the growing overseas market of cheap generic drugs, the company seems to have gone lax on quality issues. Read on to know more... (The Economist Newspaper Limited)

Functioning of economy, demystified
Since the eruption of the global financial crisis in 2008, the functioning of economies across the world have been a heated topic of debate. In this video Mr Ray Dalio explains the working of the economy in layman's terms. Watch it to understand how the economy can impact the well being of its inhabitants. (Value Investing World)

Corporate India continues to reel under rate hike
The recent hike in the repo rate further compounded funding problems of corporate India. With companies already struggling with the economic slowdown and falling profits, the rising cost of funds is adding on to their burden. Companies are deferring bond issues or raising funds at higher market rates. Read on to find out how high rates are impacting the financial health of companies... (Thomson Reuters)

Simplifying energy needs of industry
In a bid to expedite investments in the energy sector and bring in more transparency, the government has approved auction-based bidding for coal mining licenses by private companies. While bidding will be competitive for deregulated sectors such cement and steel, discounts will be offered to the regulated power sector on the basis of tariff-based bidding. Read on to know more... (Thomson Reuters)

Are dividends value accretive?
The surplus cash generated by any business can either be ploughed back into the business or returned back to shareholders. In the latter case, the cash can be returned in the form of dividends or share buyback. Which among the two options will maximize shareholder's wealth? Read on to find out... (Inside Investing)

Madhu Gupta

Madhu Gupta (Research Analyst), ValuePro has a post graduate degree in both physics and finance. Having worked with India's leading economic research agency, she has a natural flair for numbers and analytics. She brings with her a near-decade long rich experience in the field of finance. A firm believer of the principles of value investing, she looks for robust businesses with durable competitive advantages.

This article is for information purposes only. The link in this article will let the User leave www.equitymaster.com and proceed to the linked article. The User's use of each such site is subject to Terms of Use on www.equitymaster.com and other terms of use, if any, contained within each such site. Any data and charts if used, in the article have not been authenticated by Equitymaster and Equitymaster do not claim it to be accurate nor accept any responsibility for the same. The views, if any in the linked article are not of Equitymaster. Equitymaster will not be responsible for any loss or liability incurred to any person as a consequence of his or any other person on his behalf taking any investment decisions based on this article. Please read the detailed Terms of Use of the web site.

Equitymaster requests your view! Post a comment on "Ranbaxy woes don't seem to end". Click here!


More Views on News

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

ONGC to NMDC: Here are 5 Stocks Value Investors Should Closely Track (Views On News)

Nov 26, 2021

Before investing in value stocks, research the company and gain insight into why the market is discounting it.

Top 5 Stocks FIIs Bought and Sold Recently (Views On News)

Nov 25, 2021

FIIs have largely stayed on sidelines for the past few months, withdrawing money across emerging markets.

Everything to Know About the Upcoming Tega Industries IPO (Views On News)

Nov 27, 2021

Are you looking to apply for the Tega Industries IPO? You must ensure that you know specific details.

3 Charts on Why the Indian Bull Looks Tired podcast (Views On News)

Nov 27, 2021

Rahul Shah explains the key reasons behind his pessimistic outlook on the stock market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Nov 26, 2021 (Close)